Cited by 100Drug Transport and Resistance MechanismsCholesterol and Lipid MetabolismCholangiocarcinoma and Gallbladder Cancer Studies

Bile acids: From digestion to cancers

Baptissart, Marine, Vega, Aurelie, Maqdasy, Salwan, Caira, Françoise, Baron, Silvère, Lobaccaro, Jean-Marc A., Volle, David H.·2013·Biochimie

Abstract

Bile acids (BAs) are cholesterol metabolites that have been extensively studied these last decades. BAs have been classified in two groups. Primary BAs are synthesized in liver, when secondary BAs are produced by intestinal bacteria. Recently, next to their ancestral roles in digestion and fat solubilization, BAs have been described as signaling molecules involved in many physiological functions, such as glucose and energy metabolisms. These signaling pathways involve the activation of the nuclear receptor FXRα or of the G-protein-coupled receptor TGR5. These two receptors have selective affinity to different types of BAs and show different expression patterns, leading to different described roles of BAs. It has been suggested for long that BAs could be molecules linked to tumor processes. Indeed, as many other molecules, regarding analyzed tissues, BAs could have either protective or pro-carcinogen activities. However, the molecular mechanisms responsible for these effects have not been characterized yet. It involves either chemical properties or their capacities to activate their specific receptors FXRα or TGR5. This review highlights and discusses the potential links between BAs and cancer diseases and the perspectives of using BAs as potential therapeutic targets in several pathologies.

Integrity signals

Registry

Crossref · 10.1016/j.biochi.2012.06.022

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 164 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Volle, David H.
Venue
Biochimie
Publisher
Elsevier BV
Published
2013-03
Volume
95
Issue
3
Pages
504-517
ISSN
  • 0037-9042 (ISSN-L)
  • 0300-9084
OpenAlex
W2033261131
Cited by
97
References
164
Citations by year
2025: 5 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 9 · 2017: 10 · 2016: 13 · 2015: 16 · 2014: 11 · 2013: 5 · 2012: 3
FWCI
1.19
Type
journal article
Language
en
Open access
closed
Locations
  • Biochimie (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
Keywords
bile acids, primary bile acids, secondary bile acids, TGR5, nuclear receptors, G protein-coupled receptors, bile acid signaling, cholesterol metabolism, lipid digestion, energy metabolism, glucose metabolism, tumor promotion, cancer, therapeutic target
MeSH terms
Animals, Bile Acids and Salts, Digestion, Humans, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review